Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > Kirby Releases Chronic Hepatitis C Treatment Uptake in March

Kirby Releases Chronic Hepatitis C Treatment Uptake in March

News |
Hepatitis C |
  |
  |
  |
ASHM |
  |
  |
The Kirby Institute has released a report of data compiled from the PBS on the initiation of hepatitis C treatment in March.

The Kirby Institute has released a newsletter with data compiled from the Pharmaceutical Benefits Scheme on the initiation of hepatitis C treatment since new direct acting antivirals medications became publicly listed. A total of 1,811 individuals initiated chronic hepatitis C therapy. The data is broken down by each state and territory, as well as regimen and course duration.

The new medications have a high cure rate for chronic hepatitis C and fewer side effects than previous treatments.  

We are likely to see a dramatic increase in numbers in the second and possibly third month, as reimbursements for scripts move through the system and are recorded as data.​ 

Download the Kirby Report

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.